Masquerade without a mass: an unusual cause of severe acute pancreatitis.

To CA, Quigley MM, Saven A, Nicholson L

Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22.

Chen WC, Sigal DS, Saven A, Paulson JC

My treatment approach to hairy cell leukemia.

Naik RR, Saven A

Primary intraocular lymphoma: a review.

Vosganian GS, Boisot S, Hartmann KI, Freeman WR, Sharpe RW, Tripuraneni P, Saven A

Development of cladribine at Scripps for hairy cell leukemia and current results.

Torrey ML, Sigal DS, Saven A

Hairy cell leukemia: current therapies and future directions.

Vosganian GS, Sigal DS, Saven A

Beyond hairy cell: the activity of cladribine in other hematologic malignancies.

Sigal DS, Miller HJ, Schram ED, Saven A

In vivo targeting of B-cell lymphoma with glycan ligands of CD22.

Chen WC, Completo GC, Sigal DS, Crocker PR, Saven A, Paulson JC

Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies.

Burris HA, Belani CP, Kaufman PA, Gordon AN, Schwartzberg LS, Paroly WS, Shahin S, Dreiling L, Saven A

Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine.

Sigal DS, Sharpe R, Burian C, Saven A